Grant: Operating Grant - PA: HIV/AIDS Research Initiative - Biomedical/Clinical Stream
Université Laval
$361,620.00
Mechanism of inhibition of HIV LTR by TOE1
EF 2009-10
Résumé
For the HIV virus to replicate and produce new infectious viral particles, it must use the activity of a number of proteins, including host and viral proteins. One centrally important viral protein is called Tat that functions by increasing the production of viral genes. We have discovered that a newly defined protein discovered in our lab, has the capacity to block the effects of the Tat protein. Our research proposal aims at the precise molecular understanding of how TOE1 is able to accomplish this blocking effect. Our guiding aim is to assist the development of new and effective treatment strategies capable of offering relief to HIV infected AIDS patients.
Programme
Operating Grant - PA: HIV/AIDS Research Initiative - Biomedical/Clinical Stream
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
197698
Name
De Belle Ian
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Mechanism of inhibition of HIV LTR by TOE1
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$361,620
Cihrequipment2
$0
Programname2
Operating Grant - PA: HIV/AIDS Research Initiative - Biomedical/Clinical Stream
Keyworddelim
Hiv Aids; Tat; Transcriptional Inhibition
Abstract
For the HIV virus to replicate and produce new infectious viral particles, it must use the activity of a number of proteins, including host and viral proteins. One centrally important viral protein is called Tat that functions by increasing the production of viral genes. We have discovered that a newly defined protein discovered in our lab, has the capacity to block the effects of the Tat protein. Our research proposal aims at the precise molecular understanding of how TOE1 is able to accomplish this blocking effect. Our guiding aim is to assist the development of new and effective treatment strategies capable of offering relief to HIV infected AIDS patients.
Competitiondate
200909
Approvedterm2
3 yrs 0 mth
Pinamesdelim
De Belle, Ian
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $361,620~ $0~